Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy

Authors:
Top Cited Papers
Publisher website
Google Scholar
Abstract
Ionizable lipids are a key component of lipid nanoparticles, the leading nonviral messenger RNA delivery technology. Here, to advance the identification of ionizable lipids beyond current methods, which rely on experimental screening and/or rational design, we introduce lipid optimization using neural networks, a deep-learning strategy for ionizable lipid design. We created a dataset of >9,000 lipid nanoparticle activity measurements and used it to train a directed message-passing neural network for prediction of nucleic acid delivery with diverse lipid structures. Lipid optimization using neural networks predicted RNA delivery in vitro and in vivo and extrapolated to structures divergent from the training set. We evaluated 1.6 million lipids in silico and identified two structures, FO-32 and FO-35, with local mRNA delivery to the mouse muscle and nasal mucosa. FO-32 matched the state of the art for nebulized mRNA delivery to the mouse lung, and both FO-32 and FO-35 efficiently delivered mRNA to ferret lungs. Overall, this work shows the utility of deep learning for improving nanoparticle delivery.
Funding Information
  • U.S. Department of Health & Human Services | National Institutes of Health (HL162564-02, R61AI161805, HL162564-02, HL162564-02, HL152960, DK054759, 75N92019C00010, HL152960, DK054759, 75N92019C00010, HL152960, DK054759, 75N92019C00010, HL152960, DK054759, 75N92019C00010, HL152960, DK054759, 75N92019C00010)
  • Alpha-1 Foundation
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P30-CA14051)
  • Sanofi (N/a, n/a, n/a)
  • Cystic Fibrosis Foundation (WITTEN19XX0, 004831F5222)

This publication has 80 references indexed in Scilit: